Heparin-induced antibodies as a risk factor for thromboembolism and haemorrhage in patients undergoing chronic haemodialysis
- 1 September 1996
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 348 (9029) , 764
- https://doi.org/10.1016/s0140-6736(05)65684-x
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Single amino acid mutation of FCγ receptor is associated with the development of heparin‐induced thrombocytopeniaBritish Journal of Haematology, 1995
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- Laboratory diagnosis of heparin‐associated thrombocytopenia and comparison of platelet aggregation test, heparin‐induced platelet activation test, and platelet factor 4/heparin enzyme‐linked immunosorbent assayTransfusion, 1994